| 67 | 1 <html> | 
|  | 2 | 
|  | 3 <head> | 
|  | 4 <meta http-equiv=Content-Type content="text/html; charset=windows-1252"> | 
|  | 5 <meta name=Generator content="Microsoft Word 14 (filtered)"> | 
|  | 6 <style> | 
|  | 7 <!-- | 
|  | 8  /* Font Definitions */ | 
|  | 9  @font-face | 
|  | 10 	{font-family:Calibri; | 
|  | 11 	panose-1:2 15 5 2 2 2 4 3 2 4;} | 
|  | 12 @font-face | 
|  | 13 	{font-family:UICTFontTextStyleBody;} | 
|  | 14  /* Style Definitions */ | 
|  | 15  p.MsoNormal, li.MsoNormal, div.MsoNormal | 
|  | 16 	{margin-top:0in; | 
|  | 17 	margin-right:0in; | 
|  | 18 	margin-bottom:10.0pt; | 
|  | 19 	margin-left:0in; | 
|  | 20 	line-height:115%; | 
|  | 21 	font-size:11.0pt; | 
|  | 22 	font-family:"Calibri","sans-serif";} | 
|  | 23 a:link, span.MsoHyperlink | 
|  | 24 	{color:blue; | 
|  | 25 	text-decoration:underline;} | 
|  | 26 a:visited, span.MsoHyperlinkFollowed | 
|  | 27 	{color:purple; | 
|  | 28 	text-decoration:underline;} | 
|  | 29 span.apple-converted-space | 
|  | 30 	{mso-style-name:apple-converted-space;} | 
|  | 31 .MsoChpDefault | 
|  | 32 	{font-family:"Calibri","sans-serif";} | 
|  | 33 .MsoPapDefault | 
|  | 34 	{margin-bottom:10.0pt; | 
|  | 35 	line-height:115%;} | 
|  | 36 @page WordSection1 | 
|  | 37 	{size:8.5in 11.0in; | 
|  | 38 	margin:1.0in 1.0in 1.0in 1.0in;} | 
|  | 39 div.WordSection1 | 
|  | 40 	{page:WordSection1;} | 
|  | 41 --> | 
|  | 42 </style> | 
|  | 43 | 
|  | 44 </head> | 
|  | 45 | 
|  | 46 <body lang=EN-US link=blue vlink=purple> | 
|  | 47 | 
|  | 48 <div class=WordSection1> | 
|  | 49 | 
|  | 50 <p class=MsoNormalCxSpFirst style='text-align:justify'><b><span lang=EN-GB | 
|  | 51 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>References</span></b></p> | 
|  | 52 | 
|  | 53 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | 
|  | 54 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"; | 
|  | 55 color:black'>Yaari, G. and Uduman, M. and Kleinstein, S. H. (2012). Quantifying | 
|  | 56 selection in high-throughput Immunoglobulin sequencing data sets. In<span | 
|  | 57 class=apple-converted-space> </span><em>Nucleic Acids Research, 40 (17), | 
|  | 58 pp. e134–e134.</em><span class=apple-converted-space><i> </i></span>[</span><span | 
|  | 59 lang=EN-GB><a href="http://dx.doi.org/10.1093/nar/gks457" target="_blank"><span | 
|  | 60 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"; | 
|  | 61 color:#303030'>doi:10.1093/nar/gks457</span></a></span><span lang=EN-GB | 
|  | 62 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"; | 
|  | 63 color:black'>][</span><span lang=EN-GB><a | 
|  | 64 href="http://dx.doi.org/10.1093/nar/gks457" target="_blank"><span | 
|  | 65 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"; | 
|  | 66 color:#303030'>Link</span></a></span><span lang=EN-GB style='font-size:12.0pt; | 
|  | 67 line-height:115%;font-family:"Times New Roman","serif";color:black'>]</span></p> | 
|  | 68 | 
|  | 69 <p class=MsoNormalCxSpMiddle style='text-align:justify'><b><span lang=EN-GB | 
|  | 70 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Graphs</span></b></p> | 
|  | 71 | 
|  | 72 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB | 
|  | 73 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>AA | 
|  | 74 mutation frequency</span></u></p> | 
|  | 75 | 
|  | 76 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | 
|  | 77 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>For | 
|  | 78 each class, the frequency of replacement mutations at each amino acid position | 
|  | 79 is shown, which is calculated by dividing the number of replacement mutations | 
|  | 80 at a particular amino acid position/the number sequences that have an amino | 
|  | 81 acid at that particular position. Since the length of the CDR1 and CDR2 region | 
|  | 82 is not the same for every VH gene, some amino acids positions are absent. | 
|  | 83 Therefore we calculate the frequency using the number of amino acids present at | 
|  | 84 that that particular location. </span></p> | 
|  | 85 | 
|  | 86 <p class=MsoNormalCxSpMiddle style='text-align:justify'><u><span lang=EN-GB | 
|  | 87 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Antigen | 
|  | 88 selection (BASELINe)</span></u></p> | 
|  | 89 | 
|  | 90 <p class=MsoNormalCxSpMiddle style='text-align:justify'><span lang=EN-GB | 
|  | 91 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Shows | 
|  | 92 the results of the analysis of antigen selection as performed using BASELINe. | 
|  | 93 Details on the analysis performed by BASELINe can be found in Yaari et al, | 
|  | 94 PMID: 22641856. The settings used for the analysis are</span><span lang=EN-GB | 
|  | 95 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>: | 
|  | 96 focused, SHM targeting model: human Tri-nucleotide, custom bounderies. The | 
|  | 97 custom boundries are dependent on the ‘sequence starts at filter’. </span></p> | 
|  | 98 | 
|  | 99 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL | 
|  | 100 style='font-family:UICTFontTextStyleBody;color:black'>Leader: | 
|  | 101 1:26:38:55:65:104:-</span></p> | 
|  | 102 | 
|  | 103 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL | 
|  | 104 style='font-family:UICTFontTextStyleBody;color:black'>FR1: 27:27:38:55:65:104:-</span></p> | 
|  | 105 | 
|  | 106 <p class=MsoNormalCxSpMiddle style='line-height:normal'><span lang=NL | 
|  | 107 style='font-family:UICTFontTextStyleBody;color:black'>CDR1: 27:27:38:55:65:104:-</span></p> | 
|  | 108 | 
|  | 109 <p class=MsoNormalCxSpLast style='line-height:normal'><span lang=NL | 
|  | 110 style='font-family:UICTFontTextStyleBody;color:black'>FR2: 27:27:38:55:65:104:-</span></p> | 
|  | 111 | 
|  | 112 <p class=MsoNormal><span lang=NL style='font-size:12.0pt;line-height:115%; | 
|  | 113 font-family:"Times New Roman","serif"'>Hanna IJspeert, Pauline A. van | 
|  | 114 Schouwenburg, David van Zessen, Ingrid Pico-Knijnenburg, Gertjan J. Driessen, | 
|  | 115 Andrew P. Stubbs, and Mirjam van der Burg (2016). </span><span | 
|  | 116 style='font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"'>Evaluation | 
|  | 117 of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and | 
|  | 118 Adults. In <i>Frontiers in Immunolog, 7, pp. e410-410. </i>[<a | 
|  | 119 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span | 
|  | 120 style='color:windowtext'>doi:10.3389/fimmu.2016.00410</span></a>][<a | 
|  | 121 href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066086/"><span | 
|  | 122 style='color:windowtext'>Link</span></a>]</span></p> | 
|  | 123 | 
|  | 124 </div> | 
|  | 125 | 
|  | 126 </body> | 
|  | 127 | 
|  | 128 </html> |